AI Science Tracker
EN

Patient Service Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

1 discovery from 2025

Discoveries

Integrative analysis of programmed cell death pathways reveals prognostic biomarkers and immune infiltration signatures in coronary artery disease.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning analysis of coronary-artery-disease data identified the PCDscore and five core genes as prognostic biomarkers, alongside immune-infiltration signatures. These are retrospective, computational associations; they do not establish causal gene function or clinical utility.

Technology: Machine-learning feature analysis identifies a programmed-cell-death-related prognostic score (PCDscore), five core genes and associated immune-infiltration signatures.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning feature analysis identifies a programmed-cell-death-related prognostic score (PCDscore), five core genes and associated immune-infiltration signatures.
Test and result
Europe PMC abstract reports the prognostic score, five core genes and immune-infiltration analysis in the study datasets; this is retrospective biomarker analysis.
Limitation / still unknown
Prospective clinical utility and causal roles of the identified genes were not established
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12557709/ · https://pubmed.ncbi.nlm.nih.gov/41158406/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.